Anavex Life Sciences Corp. (AVXL)
1.13
-0.09
(-7.38%)
USD |
NASDAQ |
Nov 10, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Cash from Operations (Annual) : -39.04M for Sept. 30, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | -39.04M |
| September 30, 2024 | -30.81M |
| September 30, 2023 | -27.78M |
| September 30, 2022 | -24.24M |
| September 30, 2021 | -30.38M |
| September 30, 2020 | -21.29M |
| September 30, 2019 | -18.58M |
| September 30, 2018 | -12.68M |
| September 30, 2017 | -9.017M |
| September 30, 2016 | -9.237M |
| September 30, 2015 | -4.227M |
| Date | Value |
|---|---|
| September 30, 2014 | -2.659M |
| September 30, 2013 | -0.7776M |
| September 30, 2012 | -1.693M |
| September 30, 2011 | -3.802M |
| September 30, 2010 | -4.594M |
| September 30, 2009 | -2.795M |
| September 30, 2008 | -2.474M |
| September 30, 2007 | -0.3252M |
| September 30, 2006 | -0.0324M |
| September 30, 2005 | -0.0611M |
| September 30, 2004 | -0.0119M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Vaxcyte, Inc. | -655.58M |
| Foghorn Therapeutics, Inc. | -86.10M |
| Connect Biopharma Holdings Ltd. | -51.21M |
| Caribou Biosciences, Inc. | -110.99M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |